# Decoy Therapeutics Joins Webull Corporate Connect Service Platform
Canonical URL: https://biopharmsignal.com/news/SLRX/decoy-therapeutics-joins-webull-corporate-connect-service-platform
Ticker: SLRX
Company: Salarius Pharmaceuticals
Source: Salarius Pharmaceuticals
Published: 2026-02-11 14:00 EST
Original Source URL: https://investors.salariuspharma.com
## Summary

-  Connect with the Company on Webull here CAMBRIDGE, Mass. and HOUSTON, Feb. 11, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it

## Article Body
-  Connect with the Company on Webull here CAMBRIDGE, Mass. and HOUSTON, Feb. 11, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it
## Recent Company News
- 2026-04-27 12:45 EST — [Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston](https://biopharmsignal.com/news/SLRX/decoy-therapeutics-to-present-at-two-peptide-therapeutics-conferences-in-boston) — Source: Salarius Pharmaceuticals
- 2026-04-09 12:36 EST — [Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline](https://biopharmsignal.com/news/SLRX/decoy-therapeutics-builds-momentum-with-accelerating-execution-entering-a-highly-catalytic-phase-with-a-clearly-defined-path-to-clinical-development-of-its-antiviral-pipeline) — Source: Salarius Pharmaceuticals
- 2026-04-06 13:15 EST — [Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026](https://biopharmsignal.com/news/SLRX/decoy-therapeutics-to-participate-in-virtual-investor-closing-bell-event-highlighting-business-outlook-for-2026) — Source: Salarius Pharmaceuticals
- 2026-04-02 13:00 EST — [Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement](https://biopharmsignal.com/news/SLRX/decoy-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement) — Source: Salarius Pharmaceuticals
- 2026-03-11 12:30 EST — [Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform](https://biopharmsignal.com/news/SLRX/decoy-therapeutics-enters-strategic-partnership-with-quantori-to-deploy-google-cloud-native-integrated-ai-driven-peptide-design-and-molecular-simulation-platform) — Source: Salarius Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)